CardioGenesis raises $6m for minimally invasive products:
This article was originally published in Clinica
Executive Summary
CardioGenesis, which makes surgical products and accessories for transmyocardial revascularisation (TMR) and percutaneous myocardial channelling (PMC) procedures, has raised $6m from Laurus Funds. It plans to use the proceeds to introduce new minimally invasive TMR products and fund further R&D. The company also wants to obtain FDA approval for its PMC technology. Chairman, president and CEO Michael Quinn said the minimally invasive tools should help expand the number of angina patients treated with TMR. To date about 30,000 patients have been treated.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.